Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT06987279
Recruiting Not applicable

Lactobacillus Plantarum and Hormonal Regulation in Obese Women

NCT06987279 · tracked via the Priya Life Science China tracker
Sponsor
Wecare Probiotics Co., Ltd
Phase
Not applicable
Started
2025-06-10
Last updated
2025-05-23

Condition(s) studied

Obesity, Women

Investigational drug(s) / intervention(s)

ProbioticMaltodextrin

Probiotic: The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).

Maltodextrin: The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).

Study summary

To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1. Age: 18 to 40 years old, female, BMI ≥ 25 kg/m2. 2. Be willing to receive follow-up during the intervention period. 3. Be willing to provide two blood, urine and fecal samples during the intervention period. 4. Be willing to take the compound probiotics by oneself every day during the intervention period. 5. Have good hearing and be able to hear and understand all instructions during the intervention period. \- Exclusion Criteria: 1. Suffering from digestive system diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease). 2. Suffering from severe neurological disorders (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, long-term coma - excluding general anesthesia). 3. Have received/are currently receiving treatment for the following mental illnesses: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder. 4. Take medication for depression or low mood. 5. Suffering from internal organ failure (such as heart, liver or kidney failure, etc.). 6. Have received radiotherapy or chemotherapy in the past. 7. Have received general anesthesia surgery/procedures within the past three years, or plan to receive general anesthesia procedures/surgeries within the next three months during this trial. 8. Have suffered from hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past. \-

Primary outcome measure(s)

  • The changes of estradiol before and after the intervention — 0, 1, 2, 3 months
    The serum estrogen content of the subjects before and after the intervention was detected by enzyme-linked immunosorbent assay.

Trial sites (1)

FacilityCityRegionStatus
Fuwai Central-China Cardiovascular Hospital Zhengzhou Henan Recruiting

More Wecare Probiotics Co., Ltd. trials in China

Probiotic for Weight Management in Overweight and Obese Adults Starting soon
Efficacy of Lactobacillus Rhamnosus LRa05 in Gestational Diabetes Recruiting
Probiotics Improve Constipation Recruiting
Investigating the Efficacy of Probiotics in Enhancing Gastrointestinal and Immunological Health Starting soon
Probiotics for Constipation Relief in Adults Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06987279 on ClinicalTrials.gov ↗ ← All trials in China